Screening and Identification of an Immune-Associated lncRNA Prognostic Signature in Ovarian Carcinoma: Evidence from Bioinformatic Analysis
Backgrounds. The dysregulated long noncoding RNAs (lncRNAs) have been described to be crucial regulators in the progression of ovarian carcinoma. The infiltration status of immune cells is also related to the clinical outcomes in ovarian carcinoma. The present research is aimed at constructing an im...
Main Authors: | Yan Li, Fan-fan Huo, Ying-ying Wen, Miao Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2021/6680036 |
Similar Items
-
Six-lncRNA Immune Prognostic Signature for Cervical Cancer
by: Qian Chen, et al.
Published: (2020-10-01) -
Development of an Immune-Related LncRNA Prognostic Signature for Glioma
by: Yudong Cao, et al.
Published: (2021-06-01) -
Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
by: Bo Xiao, et al.
Published: (2021-09-01) -
A practical prognostic lncRNA signature for lung squamous cell carcinoma
by: Xiaoshun Shi, et al.
Published: (2017-08-01) -
Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
by: Wang Li, et al.
Published: (2020-06-01)